Here’s how we can support your weight loss journey:

1. Online consultations: We connect patients with healthcare professionals through virtual consultations, discussing weight loss goals, medical history, and other factors without needing to visit a physical clinic.
2. Personalized plans: Based on the consultations, Sublimity healthcare professionals can develop personalized weight loss plans tailored to the specific needs, preferences, and lifestyle of each patient.
3. Prescription medications: If appropriate, our medical providers can prescribe weight loss medications, such semaglutide online or other GLP-1 receptor agonists. Cost of medications is included in the program.
4. Ongoing support: Sublimity Healthcare LLC provides ongoing support and follow-up consultations with healthcare professionals to monitor progress, address any concerns, and make adjustments to the weight loss plan as needed.

Sublimity Healthcare LLC works with compounding pharmacies that are licensed at the state level to create compounded semaglutide. Compounding is regulated by both FDA and state boards of pharmacy. A licensed compounding pharmacy must comply with both federal and state laws, which include administrative requirements and quality standards.

In clinical trials lasting 56 to 68 weeks, non-diabetic participants with obesity or overweight who used GLP-1 medications alongside diet and exercise lost an average up to 15% of their body weight. Comparatively, those who only followed a diet and exercise plan achieved weight loss of 3.5% to 2.4%.

Absolutely! We understand that circumstances may change, and there are no long-term contracts or cancellation fees involved. We are committed to customer satisfaction.

Nope! We make this process simple and convenient. Through our telehealth platform, you can access a network of medical providers who can evaluate your specific needs based on your health information, and if appropriate, prescribe treatment - all for free.

1. Contraindications: Do not use semaglutide if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you are allergic to semaglutide or any of its components.
2. Pancreatitis: Semaglutide may increase the risk of pancreatitis. If you experience severe abdominal pain, with or without vomiting, consult your healthcare professional immediately.
3. Hypoglycemia: Semaglutide may increase the risk of low blood sugar, especially when combined with other diabetes medications. Monitor your blood sugar levels regularly and discuss any concerns with your healthcare provider.
4. Kidney function: Monitor kidney function, as semaglutide may affect kidney health, particularly in patients with pre-existing kidney issues.
5. Pregnancy and breastfeeding: Consult your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding, as the safety of semaglutide during these periods has not been established.

Common side effects of semaglutide are usually mild and may include:

1. Nausea
2. Vomiting
3. Diarrhea
4. Constipation
5. Abdominal pain
6. Decreased appetite
7. Indigestion

Most side effects are temporary and resolve on their own. However, if side effects persist or worsen, consult a healthcare professional for advice.